Is NewAmsterdam Pharma Company N.V. (NAMS) a Buy, Sell, or Hold?
NASDAQ : NAMS
NewAmsterdam Pharma Company N.V. — Earnings Estimates
$27.91 USD
-$0.07 (-0.25%)
- Volume
- 0
- Average Volume
- 1.29M
- Market Capitalization
- $3.26B
- P/E Ratio
- -15.42
- Dividend Yield
- 0.00%
- Price Target
- $48.00
- Year High
- $42.21
- Year Low
- $21.14
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.76
Annual earnings financials
NAMS financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
NAMS Estimated and Actual Revenue by Quarter
NAMS Estimated and Actual EPS by Quarter
NAMS Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 6 | -27.63M | -10.9M | -19.27M | -27.63M | -10.9M | -19.27M |
| 2028-09-30 | 3 | -20.81M | -8.21M | -14.52M | -20.82M | -8.21M | -14.52M |
| 2028-06-30 | 5 | -18.54M | -7.32M | -12.93M | -18.54M | -7.32M | -12.94M |
| 2028-03-31 | 3 | -14.03M | -5.53M | -9.78M | -14.03M | -5.53M | -9.78M |
| 2027-12-31 | 7 | -64.01M | -25.25M | -44.65M | -64.01M | -25.25M | -44.65M |
| 2027-09-30 | 4 | -23.97M | -9.46M | -16.72M | -23.97M | -9.46M | -16.72M |
NAMS Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 6 | -89.77M | -24.99M | -57.4M | 49.79M | 126.2M | 88.03M |
| 2028-09-30 | 3 | -103.08M | -28.69M | -65.92M | 37.51M | 95.09M | 66.32M |
| 2028-06-30 | 5 | -106.83M | -29.74M | -68.31M | 33.42M | 84.72M | 59.09M |
| 2028-03-31 | 3 | -112.62M | -31.35M | -72.02M | 25.28M | 64.08M | 44.69M |
| 2027-12-31 | 7 | 2.24M | 8.05M | 5.15M | 115.36M | 292.43M | 203.97M |
| 2027-09-30 | 4 | -64.87M | -18.06M | -41.48M | 43.2M | 109.51M | 76.38M |
NAMS Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2028-12-31 | 6 | 24.57M | 62.29M | 43.45M | 7 | -0.74124 | -0.20632 | -0.474 |
| 2028-09-30 | 3 | 18.51M | 46.93M | 32.74M | 4 | -0.85118 | -0.23692 | -0.5443 |
| 2028-06-30 | 5 | 16.5M | 41.81M | 29.16M | 6 | -0.88214 | -0.24554 | -0.5641 |
| 2028-03-31 | 3 | 12.48M | 31.63M | 22.06M | 4 | -0.92999 | -0.25885 | -0.5947 |
| 2027-12-31 | 7 | 56.94M | 144.33M | 100.67M | 6 | 0.01849892 | 0.06646147 | 0.0425 |
| 2027-09-30 | 4 | 21.32M | 54.05M | 37.7M | 3 | -0.53563 | -0.14909 | -0.34252 |